company

EU BIOTEK AS

2040 KLØFTA

Return on Equity
44,97 %
Current Ratio
0,54
Debt-to-Equity Ratio
−0
Key figures (NOK)2022
Revenue3 309 000
Net Income−76 000
Total Assets199 000
Total Equity−169 000
Income (NOK)2022
Revenue3 309 000
Expenditure3 409 000
Operating Profit−100 000
Financial Income106 000
Financial Costs73 000
Financial Balance33 000
Earnings Before Tax−67 000
Tax10 000
Net Income−76 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets199 000
Total Assets199 000
Total Retained Equity−199 000
Total Equity−169 000
Total Long-Term Debt0
Total Current Debt368 000
Total Equity and Debt199 000
Cash flow (NOK)2022
Sales Income3 309 000
Other Income0
Revenue3 309 000
Cost of Goods Sold2 054 000
Salary Costs453 000
Depreciation0
Impairment0
Expenditure3 409 000
Operating Profit−100 000
Financial Income106 000
Financial Costs73 000
Financial Balance33 000
Dividends0
Net Income−76 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments0
Cash, Bank58 000
Total Current Assets199 000
Total Assets199 000
Total Equity−169 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors202 000
Unpaid Taxes64 000
Dividends0
Other Current Debt102 000
Total Current Debt368 000
Total Equity and Debt199 000
Financial indicators2022
Return on Equity44,97 %
Debt-to-Equity Ratio−0
Operating Profit Margin−3,02 %
Current Ratio0,54
Quick Ratio0,54
Equity Ratio−0,85
Gross Profit Margin37,93 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English